Cogent Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:COGT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
16 Feb 24	BuyUS$8,749,995	Fairmount Funds Management LLC	Company		1,166,666	US$7.50
09 Jun 23	BuyUS$9,600,000	Fairmount Funds Management LLC	Company		800,000	US$12.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COGT?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,296	0.00131%
Private Companies	39,856	0.0403%
VC/PE Firms	11,343,542	11.5%
Hedge Funds	16,357,134	16.5%
Institutions	71,195,685	72%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.7%.

Top Shareholders

Top 25 shareholders own 88.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.72%	Kynam Capital Management, LP	7,377,116	US$48.0m	26%	3.44%
7.07%	BlackRock, Inc.	6,755,584	US$43.9m	9.9%	no data
6.5%	TCG Crossover Management, LLC	6,214,375	US$40.4m	10.4%	3.44%
6.06%	Commodore Capital LP	5,794,777	US$37.7m	4.11%	2.42%
5.73%	Suvretta Capital Management, LLC	5,481,034	US$35.6m	47.7%	1.44%
5.55%	FMR LLC	5,302,577	US$34.5m	16%	no data
5.36%	VR Adviser, LLC	5,129,167	US$33.3m	9.5%	1.76%
5.31%	Point72 Asset Management, L.P.	5,081,323	US$33.0m	-3.1%	0.06%
4.94%	Fairmount Funds Management LLC	4,725,641	US$30.7m	32.8%	2.92%
4.74%	The Vanguard Group, Inc.	4,534,655	US$29.5m	3.69%	no data
4.34%	State Street Global Advisors, Inc.	4,150,615	US$27.0m	39.9%	no data
3.05%	Redmile Group, LLC	2,914,022	US$18.9m	41.9%	0.74%
2.93%	Millennium Management LLC	2,797,244	US$18.2m	2,160%	0.01%
2.35%	Vivo Capital, LLC	2,244,941	US$14.6m	0%	1.1%
2.34%	Eventide Asset Management, LLC	2,232,968	US$14.5m	3.86%	0.23%
2.3%	Morgan Stanley, Investment Banking and Brokerage Investments	2,198,408	US$14.3m	2,650%	no data
2.09%	Frazier Life Sciences Management, LP	1,995,267	US$13.0m	32.9%	0.55%
1.81%	Geode Capital Management, LLC	1,728,782	US$11.2m	4.95%	no data
1.71%	Dimensional Fund Advisors LP	1,636,834	US$10.6m	3.62%	no data
1.2%	Medical Strategy GmbH, Asset Management Arm	1,150,422	US$7.5m	-1.77%	0.42%
1.18%	Crestline Investors Inc.	1,131,023	US$7.4m	0%	0.63%
1.17%	Perceptive Advisors LLC	1,122,958	US$7.3m	-51.4%	0.16%
1.14%	Deerfield Management Company, L.P. Series C	1,089,345	US$7.1m	0%	0.13%
1.01%	Silverarc Capital Management, LLC	966,748	US$6.3m	48.4%	1.77%
0.83%	Woodline Partners LP	790,484	US$5.1m	559%	0.05%